Navigation Links
Less Than Two-Thirds of Surveyed Pharmacy Directors Expect to Reimburse Both Onglyza and Alogliptin Once They are Available for the Treatment of Type 2 Diabetes
Date:2/2/2009

Contract Negotiation is Leading Factor in Improving Formulary Placement of Newer Entrants to Antidiabetic Market, According to a New Report from HealthLeaders-InterStudy and Fingertip Formulary

NASHVILLE, Tenn. and GLEN ROCK, N.J., Feb. 2 /PRNewswire/ -- HealthLeaders-InterStudy and Fingertip Formulary find that less than two-thirds of surveyed pharmacy directors expect to reimburse both Bristol-Myers Squibb/AstraZeneca's Onglyza and Takeda's alogliptin once they become available. Sixty-two percent of surveyed pharmacy directors say they expect their managed care organization to reimburse both products, while 26 percent say they expect their organization to reimburse only one. Seventy-eight percent of surveyed pharmacy directors say it is either likely or very likely they will reimburse Novo Nordisk's Victoza upon FDA approval.

According to the new Formulary Forum report entitled Formulary Advantages in Type 2 Diabetes: Impact of Current and Future DPP-IV Inhibitors and GLP-1 Analogues on Advantaged Reimbursement Status for Key Brands, 62 percent of surveyed pharmacy directors say their managed care organization would place Onglyza or alogliptin on Tier 1 or 2 if the agent were priced at $4.00 per treated day, but fewer (24 percent) would place it on Tier 1 or 2 if priced at $5.00 per treated day.

The report also finds that more surveyed pharmacy directors say that contract negotiations are important when improving the formulary position of Merck's Januvia and Amylin/Eli Lilly's Byetta than say safety or efficacy gains leading to downstream cost savings. Both recent entrants in the antidiabetic market, Januvia and Byetta are covered on 85 percent of health plans.

"Our survey reveals that contracting is a leading factor for pharmacy directors looking at products in the antidiabetic market," said Michael Malec
'/>"/>

SOURCE HealthLeaders-InterStudy; Fingertip Formulary
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. More than two-thirds of sexually active NYC youth use condoms, but other forms of birth control lag
2. Survey: Two-thirds of Illinois public schools provide comprehensive sex education
3. Erbitux Works Well for Two-Thirds of Colon Cancer Patients
4. UNC study: Two-thirds of severe sports injuries to female students due to cheerleading
5. Almost Two-Thirds of Americans Meet Exercise Guidelines
6. Despite Availability of Generic Equivalents, Two-Thirds of Neurologists Will Continue to Prescribe Branded Anti-Epileptic Drugs to Epilepsy Patients
7. World Vision Index of Concern: Half of Americans Surveyed Said They Would Be Willing to Pay More Taxes to Combat AIDS
8. Eighty-Nine Percent of Surveyed Rheumatologists Say They Will Prescribe Roche/Chugais Actemra for Rheumatoid Arthritis
9. Surveyed Neurologists in Both the U.S. and Europe Would Welcome an Antiepileptic Drug That is Administered Once-Daily
10. Half of Full-Time Employees Surveyed Dont Understand Health Insurance Coverage for Cancer-Related Medical Expenses
11. Surveyed Gastroenterologists Indicate That Humira Has Advantages Over Remicade in Maintaining Clinical Remission of Crohns Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... at the University of California, San Diego School of ... in chili peppers produces chronic activation of a ... a reaction that ultimately reduces the risk of colorectal ... 1, 2014 issue of The Journal of Clinical ... TRPV1, was originally discovered in sensory neurons, where it ...
(Date:8/1/2014)... 2014 Stryker hip lawsuits ( ... 2012 Rejuvenate and ABG II Modular-Neck Hip Stem ... Bergen County Superior Court, Bernstein Liebhard LLP reports. ... Court has issued a Final Amended Stipulated ... hard copy and electronic materials produced by any ...
(Date:8/1/2014)... MN (PRWEB) August 01, 2014 Summer is ... are most active during the summer, and they can be ... Minnesota is ready to help all their customers get rid ... between 3,000 and 6,000 eggs in the summer, which is ... to live in tall grass and woodland areas and carry ...
(Date:8/1/2014)... 01, 2014 The American Telemedicine ... Harper (R-MS), and Peter Welch (D-VT), for their ... Telehealth Parity Act of 2014, which improves telemedicine ... effort to improve healthcare access and affordability using ... of ATA. "These cost-saving provisions are critical to ...
(Date:8/1/2014)... The "Antimicrobial Coatings Market by ... Oxide, Titanium Dioxide, and Zinc Omadine), Application (Indoor ... & Beverages, Textiles, and others), & Geography (North ... and Forecasts to 2018" analyzes the Antimicrobial Coatings ... trends in the diverse geographical regions. , Browse ...
Breaking Medicine News(10 mins):Health News:Pepper and halt: Spicy chemical may inhibit gut tumors 2Health News:Stryker Hip Lawsuit News: New Order Issued in New Jersey Stryker Hip Recall Litigation, Bernstein Liebhard LLP Reports 2Health News:Stryker Hip Lawsuit News: New Order Issued in New Jersey Stryker Hip Recall Litigation, Bernstein Liebhard LLP Reports 3Health News:Tis the Season for Tick Prevention 2Health News:ATA Applauds Bill on Medicare Telemedicine Improvements 2Health News:Antimicrobial Coatings Market Projected to Reach $2.9 Billion by 2018 – Report by MarketsandMarkets 2Health News:Antimicrobial Coatings Market Projected to Reach $2.9 Billion by 2018 – Report by MarketsandMarkets 3Health News:Antimicrobial Coatings Market Projected to Reach $2.9 Billion by 2018 – Report by MarketsandMarkets 4
... NEW YORK, March 19 More than 90% ... market, due to the lack of,effectiveness or adverse ... positives could be avoided with pre-clinical tests using ... to,Kalorama Information,s new report Stem Cells: Worldwide Markets ...
... 19, 2008 The Russell Berrie Foundation has donated ... Hospital, as part of a focused effort to provide ... research initiatives, toward a cure, the Medical Center gratefully ... diabetes is a disease in which the bodys failure ...
... on Food Safety and Quality, ANN ARBOR, ... Spartan Stores is the largest supermarket chain in ... (Logo: http://www.newscom.com/cgi-bin/prnh/20070816/DCTH039LOGO ), Spartan ... and,retailers, is going beyond standard Food Code requirements ...
... of Howard G. Smith,announces that a securities class action ... purchased the publicly traded securities of Vertex,Pharmaceuticals Inc. ("Vertex" ... 2007 and November 2, 2007, inclusive (the "Class Period"). ... District Court for the,District of Massachusetts., The Complaint ...
... join panel after key ground rules established, OAKLAND, ... employed by Sutter Health,s,California Pacific Medical Center and St. ... Panel formed to develop a plan for the future ... panel after its co-chairs, with the,agreement of city leaders ...
... altered form of natural compound found in heparin samples ... officials say they,ve identified the contaminant found in the ... allergic reactions and possibly 19 deaths in the United ... oversulfated condroitin sulfate, but U.S. Food and Drug Administration ...
Cached Medicine News:Health News:Stem Cell Technology Offers Promise of Huge Savings for Drug Developers 2Health News:Columbia University Medical Center/NYPH receive $28 million donation toward curing diabetes 2Health News:Columbia University Medical Center/NYPH receive $28 million donation toward curing diabetes 3Health News:Spartan Stores Becomes Largest U.S. Supermarket Chain to Receive NSF Shop Fresh(TM) Certification 2Health News:Spartan Stores Becomes Largest U.S. Supermarket Chain to Receive NSF Shop Fresh(TM) Certification 3Health News:UHW Joins Blue Ribbon Panel on the Future of St. Luke's Hospital 2Health News:FDA Identifies Contaminant in Blood-Thinning Drug 2Health News:FDA Identifies Contaminant in Blood-Thinning Drug 3
(Date:8/1/2014)... 2014 RoundTable Healthcare Partners ("RoundTable"), an ... healthcare industry, announced today the sale of Vesta ... Lubrizol, a Berkshire Hathaway company, is a specialty ... customers in the global transportation, industrial and consumer ... Vesta is an ISO-13485 certified medical ...
(Date:8/1/2014)... NORTH CHICAGO , Ill. and PALO ... (NYSE: ABBV) and Cystic Fibrosis Research, Inc. (CFRI) today announced ... in the cystic fibrosis (CF) community through the CFChef ... to September 15, 2014, as part of AbbVie,s CFChef ... caregivers – to encourage patients to maintain a healthy ...
(Date:8/1/2014)... Mass. , Aug. 1, 2014  NxStage Medical, Inc. ... dialysis products, today announced that Jeffrey H. Burbank , ... Officer, will present at the 34 th Annual Canaccord ... Boston, MA , on Wednesday, August 13 th ... will be made available at http://ir.nxstage.com/ .  ...
Breaking Medicine Technology:RoundTable Healthcare Partners Announces Sale of Vesta Funding, Inc. to The Lubrizol Corporation 2AbbVie and Cystic Fibrosis Research, Inc. (CFRI) Team Up to Raise Awareness of the Nutritional Needs of CF Patients through the CFChef Shares Program 2AbbVie and Cystic Fibrosis Research, Inc. (CFRI) Team Up to Raise Awareness of the Nutritional Needs of CF Patients through the CFChef Shares Program 3NxStage to Present at the 34th Annual Canaccord Genuity Growth Conference 2
... 6, 2012  PAREXEL International Corporation (NASDAQ: PRXL ... that Ramita Tandon, Global Head, Late Phase Clinical Trials ... Operations at PAREXEL will address innovative approaches to late ... ( SCOPE ), to be held February 7-9, 2012 ...
... New York, February 6, 2012 In the news ... of USD 6.8 billion in 2015, China Osteoporosis Market Will be ... 11:30 GMT, by Transparency Market Research over PR Newswire, we are ... "Market Size of USD 6.8 billion" has been changed to "Market ...
Cached Medicine Technology:PAREXEL to Address Innovative Approaches to Late Stage Development at Summit for Clinical Ops Executives 2PAREXEL to Address Innovative Approaches to Late Stage Development at Summit for Clinical Ops Executives 3PAREXEL to Address Innovative Approaches to Late Stage Development at Summit for Clinical Ops Executives 4CORRECTION - Transparency Market Research: Global Osteoporosis Market is Expected to Attain a Market Size of USD 11.4 billion in 2015, China Osteoporosis Market Will be Worth USD 2.5 Billion in 2015 2CORRECTION - Transparency Market Research: Global Osteoporosis Market is Expected to Attain a Market Size of USD 11.4 billion in 2015, China Osteoporosis Market Will be Worth USD 2.5 Billion in 2015 3CORRECTION - Transparency Market Research: Global Osteoporosis Market is Expected to Attain a Market Size of USD 11.4 billion in 2015, China Osteoporosis Market Will be Worth USD 2.5 Billion in 2015 4
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: